‘Nature’ features Isis flexible displays
A new discovery being commercialised by Isis will make it possible to create pixels just a few hundred nanometres across.
We publish news of technology innovations, investment opportunities, together with updates from spinout & startup companies and licensees
A new discovery being commercialised by Isis will make it possible to create pixels just a few hundred nanometres across.
Brainomix Ltd, a start-up from the Isis Software Incubator has been announced as a finalist in the ICT category of the Academic Enterprise Awards 2014.
The eCOA Forum brings together world leaders in PRO development and health outcomes.
Isis is working to commercialise smart glasses developed at Oxford to assist people with failing vision.
The Isis Software Incubator, part of Oxford University Innovation, the University of Oxford’s technology commercialisation company, and City University London, have announced a new partnership.
Gene therapy specialist Oxford Biomedica has raised £20m to fund its portfolio of ophthalmology, CNS and cancer treatments.
An Oxford DPhil student has discovered that treating enzymes with a bacterial superglue allows them to be boiled without loss of function.
'Nature' article mentions the £1.25m University of Oxford Isis Fund as part of a growing trend for Universities and technology commercialisation groups to increase their role in funding early research to bring discoveries to market.
Oxford University Innovation (Hong Kong) is pleased to announce the launch of a new Industry Alliance Programme which builds on success of an earlier pilot auto industry support programme.
Should a breathless child with fever be treated with antibiotics in case they have pneumonia? This is the question emergency doctors ask themselves many times a day, and currently it takes over 24 hours to get a definitive answer.